(Q35557859)

8 August 2017

title

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study (English)

1 reference

8 August 2017

main subject

ankylosing spondylitis

1 reference

1 reference

3

Daniel Wendling

1 reference

8 August 2017

Denis Mulleman

1

1 reference

8 August 2017

Francine Lauféron

2

1 reference

8 August 2017

David Ternant

4

1 reference

8 August 2017

Emilie Ducourau

5

1 reference

8 August 2017

Gilles Paintaud

6

1 reference

8 August 2017

Philippe Goupille

7

1 reference

8 August 2017

publication date

3 June 2011

1 reference

Arthritis Research and Therapy

8 August 2017

published in

1 reference

8 August 2017

volume

13

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

R82

1 reference

https://scigraph.springernature.com/pub.10.1186/ar3350

8 August 2017

exact match

0 references

cites work

''R"--project for statistical computing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Methotrexate for ankylosing spondylitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

12 July 2018

1 reference

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab.

21 January 2018

1 reference

Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study

21 January 2018

1 reference

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in t

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218893

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

26 September 2018

1 reference

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

21 January 2018

1 reference

Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab

21 January 2018

1 reference

12 December 2020

Is methotrexate effective in ankylosing spondylitis?

1 reference

12 December 2020

Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)

1 reference

12 December 2020

Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR3350

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference